IGC Pharma (IGC) Curent Deferred Tax Liability (2011 - 2012)

IGC Pharma (IGC) reported Curent Deferred Tax Liability of $135980.0 for Q4 2012, little changed year-over-year from $135980.0 in Q1 2012, and little changed quarter-over-quarter from $135980.0 in Q3 2012.

IGC Pharma (IGC) Curent Deferred Tax Liability (2011 - 2012) Analysis & Trends

IGC Pharma (IGC) has 2 years of Curent Deferred Tax Liability data on file, last reported at $135980.0 in Q4 2012.

  • Curent Deferred Tax Liability for Q4 2012 came in at $135980.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2012 was $135980.0 (changed 0.0% YoY), and the FY2012 annual result was $135980.0, changed N/A from the prior year.
  • Curent Deferred Tax Liability was little changed at $135980.0 in Q4 2012 per IGC's latest filing, from $135980.0 in the prior quarter.
  • Over five years, Curent Deferred Tax Liability peaked at $135980.0 in Q4 2011 and troughed at $135980.0 in Q4 2011.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 IGC Pharma 27.49 Mn 27.22 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2012 135,980.00
Dec 31, 2012 135,980.00
Sep 30, 2012 135,980.00
Sep 30, 2012 135,980.00
Jun 30, 2012 135,980.00
Jun 30, 2012 135,980.00
Mar 31, 2012 135,980.00
Mar 31, 2012 135,980.00
Dec 31, 2011 135,980.00
Dec 31, 2011 135,980.00